Stocks of the Hour: Firebrick Pharma, Critical Resources, Blue Star Helium
Stocks of the Hour: Firebrick Pharma, Critical Resources, Blue Star Helium
Firebrick Pharma (ASX:FRE) has announce that its Nasodine Nasal Spray product is being launched in the United States today. The product will be promoted for "nasal hygiene" without any therapeutic claims. Shares are trading 82.35 per cent higher at 9.3 cents.
Firebrick Pharma（澳大利亚证券交易所股票代码：FRE）宣布，其纳索丁鼻腔喷雾剂产品将于今天在美国上市。该产品将在没有任何治疗要求的情况下推广 “鼻腔卫生”。股价上涨82.35％，至9.3美分。
Critical Resources (ASX:CRR) has announced 8km of highly prospective anomalies and follow-up targets at the company's flagship Mavis Lake Lithium Project in Ontario, Canada. The magnetic anomalies are interpreted as either being extensions of known pegmatites or representing additional pegmatite discoveries/significant structural features. Shares are trading 16.67 per cent higher at 1.4 cents.
关键资源（澳大利亚证券交易所股票代码：CRR）宣布了该公司位于加拿大安大略省的旗舰Mavis Lake锂项目的8公里极具前景的异常情况和后续目标。磁异常被解释为要么是已知伟晶岩的延伸，要么代表其他伟晶岩的发现/重要的结构特征。股价上涨16.67％，至1.4美分。
Blue Star Helium (ASX:BNL, OTCQB: BSNLF) has announced the maiden helium development well at Galactica/Pegasus is on track for drilling this quarter. The well site location has been inspected, and access ensured with landowner and construction crew engaged for pad and access upgrades, which is expected to commence this week. Shares are trading 16.67 per cent higher at 0.7 cents.
蓝星氦气（澳大利亚证券交易所股票代码：BNL，OTCQB：BSNLF）宣布，位于Galactica/Pegasus的首口氦气开发井有望在本季度进行钻探。井场位置已经过检查，并确保了准入，土地所有者和施工人员参与了停机坪和通道升级，预计将于本周开始。股价上涨16.67％，至0.7美分。
